Biofactors 32:17983 Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009) Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness
Gonnelli S, Caffarelli C, Del Santo K, Cadirni A, Guerriero C, Lucani B, et al
Semaglutide 2 4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Protects against environmental stressors
Camargo, Lorena R
However, growing evidence shows that pharmaceutical companies failed to adequately warn patients and doctors about serious health risks that can develop during or after treatment